CSIMarket
 


Cel sci Corporation  (CVM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CVM's Net Income Growth by Quarter and Year

Cel Sci's Net Income results by quarter and year




CVM Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter September - -5.55 -4.85 -14.94
III Quarter June -9.20 -10.28 -12.08 -6.01
II Quarter March -11.28 -9.09 -6.45 -4.71
I Quarter December -8.02 -5.53 1.25 -6.19
FY   -28.50 -30.45 -22.13 -31.85



CVM Net Income third quarter 2021 Y/Y Growth Comment
Cel sci Corporation in the third quarter recorded net loss of $ -9.20 millions.

According to the results reported in the third quarter, Cel Sci Corporation achieved the best Net Income growth in Biotechnology & Drugs industry. While Cel Sci Corporation' s Net Income no change of % ranks overall at the positon no. in the third quarter.




CVM Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - - - -
I Quarter December - - - -
FY   - - - -

Financial Statements
Cel Sci's third quarter 2021 Net Income $ -9.20 millions CVM's Income Statement
Cel Sci's third quarter 2020 Net Income $ -10.28 millions Quarterly CVM's Income Statement
New: More CVM's historic Net Income Growth >>


CVM Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter September - - - -
III Quarter June - - - -
II Quarter March - - - -
I Quarter December - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Cel Sci's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CVM's III. Quarter Q/Q Net Income Comment
Although Cel sci Corporation in the III. Quarter 2021 revealed net loss of $ -9.20 millions, some analyst point out, that those numbers show recovery relative to the -11.28 millions in the second quarter.

Within Biotechnology & Drugs industry Cel sci Corporation achieved highest sequential Net Income growth. While Cel Sci's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CVM's III. Quarter Q/Q Net Income Comment
Although Cel sci Corporation in the III. Quarter 2021 admitted net loss of $ -9.20 millions, management point out, that current results are improvement relative to the -11.28 millions in the second quarter.

Within Biotechnology & Drugs industry Cel sci Corporation achieved highest sequential Net Income growth. While Cel Sci's Net Income growth quarter on quarter, overall rank is .


Cel Sci's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Net Income 12 Months Ending $ -34.05 $ -35.13 $ -32.94 $ -30.28 $ -29.75
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Cel Sci Corporation' has realized cumulative trailing twelve months net loss of $ -34 millions in the Jun 30 2021 period.

Cel sci Corporation achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Cel Sci Corporation' has realized cumulative trailing twelve months net loss of $ -34 millions in the Jun 30 2021 period.

Cel sci Corporation achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CVM's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CVM's Competitors
Net Income Growth for Cel Sci's Suppliers
Net Income Growth for CVM's Customers

You may also want to know
CVM's Annual Growth Rates CVM's Profitability Ratios CVM's Asset Turnover Ratio CVM's Dividend Growth
CVM's Roe CVM's Valuation Ratios CVM's Financial Strength Ratios CVM's Dividend Payout Ratio
CVM's Roa CVM's Inventory Turnover Ratio CVM's Growth Rates CVM's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2021
Eli Lilly And Company-1.54%$ -1.544 millions
Bio rad Laboratories Inc -5.41%$ -5.413 millions
Corcept Therapeutics Inc-6.37%$ -6.368 millions
Zynex Inc-6.93%$ -6.927 millions
Pacific Health Care Organization Inc-11.14%$ -11.144 millions
Lhc Group Inc-19.11%$ -19.114 millions
Tenax Therapeutics Inc-20.01%$ -20.010 millions
Apollo Medical Holdings Inc -26.51%$ -26.507 millions
Reynolds Consumer Products Inc -28.57%$ -28.571 millions
Msa Safety Inc-30.27%$ -30.267 millions
Chemed Corporation-31.16%$ -31.156 millions
Supernus Pharmaceuticals inc -31.56%$ -31.560 millions
Co diagnostics Inc -34.79%$ -34.787 millions
Biogen Inc -36.17%$ -36.166 millions
Petmed Express Inc-43.00%$ -42.997 millions
The Pennant Group Inc -43.07%$ -43.071 millions
Neurocrine Biosciences Inc -46.86%$ -46.859 millions
Hill rom Holdings Inc -47.60%$ -47.604 millions
Incyte Corp-48.52%$ -48.516 millions
Merck and Co Inc -48.64%$ -48.638 millions
Molecular Templates Inc -50.04%$ -50.042 millions
Meridian Bioscience Inc -57.58%$ -57.578 millions
Healthcare Services Group Inc -58.59%$ -58.595 millions
Community Health Systems Inc -60.22%$ -60.215 millions
Pro Dex Inc-66.50%$ -66.496 millions
Hanger inc -67.29%$ -67.286 millions
Electromed Inc -69.47%$ -69.467 millions
Tivity Health Inc -70.69%$ -70.689 millions
Quidel Corporation-71.81%$ -71.807 millions
Alpha Pro Tech Ltd-74.13%$ -74.134 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TERN's Profile

Stock Price

TERN's Financials

Business Description

Fundamentals

Charts & Quotes

TERN's News

Suppliers

TERN's Competitors

Customers & Markets

Economic Indicators

TERN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071